miércoles, 23 de marzo de 2016

Cancer Information Highlights

Cancer Information Highlights

National Cancer Institute

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
HPV factoid HPV Infections Targeted by Vaccine Have Decreased in U.S.

A new study shows that infection with four types of HPV targeted by an HPV vaccine has declined among teenage girls in the U.S. HPV stands for human papillomavirus.
Liver Cancer Statistics Video

This video explores the link between hepatitis virus infection and liver cancer. You can also learn about prevention, treatments, and cancer statistics that show us which groups of people are most at risk.
sunset ocean view in Mykonos Relaxation Tips for Cancer Patients

Many people with cancer have found that doing relaxation or imagery exercises helps them cope with pain and stress.
PDQ on tablet Breast Cancer Treatment

Our revised PDQ summary includes updated treatment options for the different types of breast cancer.
A female pharmacist is examining a vial in a pharmacy. Drug Approved for Non-Hodgkin Lymphoma

We've updated our drug summary on obinutuzumab to include the recent approval from the Food and Drug Administration (FDA). Obinutuzumab is now approved for treatment of follicular lymphoma, a type of non-Hodgkin lymphoma.
Also of Interest
Understanding Cervical Changes

This publication provides information about Pap and HPV testing and how to interpret results from these tests. It also describes common changes that can occur in the cervix and how they are treated.
Liver Cancer

This page takes you to more information about liver cancer, including its link to hepatitis, how it can be prevented, and the different types of liver cancer and how they can be treated.
The Role of Off-Label Drug Use in Cancer Treatment

Off-label drug use is common in cancer treatment. Our information explains what off-label drug use is and the important role it plays in cancer treatment.

No hay comentarios:

Publicar un comentario